story of the week
Risks Associated With Topical Carbonic Anhydrase Inhibitor Use in Patients With Glaucoma and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients with Chronic Kidney Disease: A Nationwide Population-Based Study
Am J Ophthalmol 2023 May 04;[EPub Ahead of Print], YC Wang, XC Ling, WH Tsai, JS Liu, KL KuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.